Centene (CNC) Competitors $57.72 -0.76 (-1.31%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$57.77 +0.06 (+0.10%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, CLOV, TRUP, and NEUEShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), Trupanion (TRUP), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Alignment Healthcare Clover Health Investments Trupanion NeueHealth Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment. Does the MarketBeat Community believe in ELV or CNC? Centene received 183 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.36% of users gave Centene an outperform vote while only 67.16% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformElevance HealthOutperform Votes86967.16% Underperform Votes42532.84% CenteneOutperform Votes105273.36% Underperform Votes38226.64% Does the media refer more to ELV or CNC? In the previous week, Elevance Health had 15 more articles in the media than Centene. MarketBeat recorded 39 mentions for Elevance Health and 24 mentions for Centene. Elevance Health's average media sentiment score of 1.47 beat Centene's score of 1.02 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 34 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 15 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ELV or CNC? Elevance Health currently has a consensus price target of $517.03, suggesting a potential upside of 34.28%. Centene has a consensus price target of $79.92, suggesting a potential upside of 38.48%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.88Centene 1 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53 Which has more volatility & risk, ELV or CNC? Elevance Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Do insiders & institutionals believe in ELV or CNC? 89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by company insiders. Comparatively, 0.3% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ELV or CNC more profitable? Elevance Health has a net margin of 3.38% compared to Centene's net margin of 2.03%. Elevance Health's return on equity of 18.28% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health3.38% 18.28% 6.72% Centene 2.03%13.85%4.54% Which has stronger earnings & valuation, ELV or CNC? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$177.01B0.50$5.98B$25.6115.03Centene$163.07B0.18$3.31B$6.249.25 SummaryElevance Health beats Centene on 15 of the 19 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$28.63B$57.22B$5.78B$20.06BDividend YieldN/A1.63%4.78%3.65%P/E Ratio9.2519.7426.4634.89Price / Sales0.180.56457.0115.65Price / Cash5.838.8144.0420.85Price / Book1.084.697.634.92Net Income$3.31B$2.21B$3.18B$1.02B7 Day Performance1.49%-2.52%-1.82%-1.05%1 Month Performance-9.37%-6.27%0.22%-1.39%1 Year Performance-27.10%28.41%17.49%13.93% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9826 of 5 stars$57.72-1.3%$79.92+38.5%-27.1%$29.01B$163.07B9.2567,700Positive NewsGap DownELVElevance Health4.8639 of 5 stars$389.58-0.5%$517.03+32.7%-24.4%$90.35B$177.01B15.21104,900Analyst DowngradePositive NewsGap DownCIThe Cigna Group4.934 of 5 stars$292.12-2.6%$373.69+27.9%-12.7%$81.25B$247.12B23.8772,500Analyst UpgradePositive NewsHUMHumana4.6238 of 5 stars$253.61+0.3%$293.05+15.6%-30.4%$30.54B$106.37B22.4667,600Dividend AnnouncementAnalyst ForecastGap DownMOHMolina Healthcare4.8792 of 5 stars$272.28+0.6%$355.67+30.6%-28.8%$15.57B$40.65B13.33123,123Analyst ForecastGap DownUNHUnitedHealth Group4.9913 of 5 stars$523.48-1.4%$629.32+20.2%-10.8%$481.75B$400.28B33.77440,000News CoverageGap DownOSCROscar Health3.4022 of 5 stars$13.40+2.6%$21.56+61.0%-12.5%$3.31B$9.18B-669.422,400Options VolumeGap UpALHCAlignment Healthcare1.3265 of 5 stars$13.68-1.4%$11.88-13.2%+105.4%$2.62B$2.47B-17.771,536Insider TradeNews CoverageCLOVClover Health Investments2.2526 of 5 stars$4.46-1.8%$5.00+12.1%+365.3%$2.23B$2.03B-22.30680Positive NewsTRUPTrupanion3.7159 of 5 stars$49.63+1.2%$45.33-8.7%+39.0%$2.10B$1.11B-155.091,142Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageNEUENeueHealth0.9604 of 5 stars$7.33-0.1%$7.00-4.5%-11.3%$60.69M$1.16B-0.141,252 Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives ALHC Alternatives CLOV Alternatives TRUP Alternatives NEUE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.